Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

Original publication

DOI

10.1016/j.euroneuro.2015.08.019

Type

Journal article

Journal

Eur Neuropsychopharmacol

Publication Date

12/2015

Volume

25

Pages

2318 - 2325

Keywords

Adherence, Mode of action, Neuroscience, Nomenclature, Pharmacological domain, Psychotropic drugs, Humans, Neurosciences, Psychotropic Drugs, Terminology as Topic